Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?

Ross M. Simon, Lauren E. Howard, Stephen J. Freedland, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher Amling, Matthew R. Cooperberg, Adriana C. Vidal

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: To determine if men with adverse pathology but undetectable ultrasensitive (

Original languageEnglish (US)
JournalBJU International
DOIs
StateAccepted/In press - 2015

Fingerprint

Prostate-Specific Antigen
Prostatectomy
Radiation
Pathology

Keywords

  • Adjuvant radiotherapy
  • Prostate
  • Prostate-specific antigen
  • Prostatic neoplasm
  • Recurrence

ASJC Scopus subject areas

  • Urology

Cite this

Simon, R. M., Howard, L. E., Freedland, S. J., Aronson, W. J., Terris, M. K., Kane, C. J., ... Vidal, A. C. (Accepted/In press). Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted? BJU International. https://doi.org/10.1111/bju.13182

Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy : Is adjuvant radiation warranted? / Simon, Ross M.; Howard, Lauren E.; Freedland, Stephen J.; Aronson, William J.; Terris, Martha K.; Kane, Christopher J.; Amling, Christopher; Cooperberg, Matthew R.; Vidal, Adriana C.

In: BJU International, 2015.

Research output: Contribution to journalArticle

Simon, Ross M. ; Howard, Lauren E. ; Freedland, Stephen J. ; Aronson, William J. ; Terris, Martha K. ; Kane, Christopher J. ; Amling, Christopher ; Cooperberg, Matthew R. ; Vidal, Adriana C. / Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy : Is adjuvant radiation warranted?. In: BJU International. 2015.
@article{20f1615ff71546389c691db26308f16e,
title = "Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?",
abstract = "Objectives: To determine if men with adverse pathology but undetectable ultrasensitive (",
keywords = "Adjuvant radiotherapy, Prostate, Prostate-specific antigen, Prostatic neoplasm, Recurrence",
author = "Simon, {Ross M.} and Howard, {Lauren E.} and Freedland, {Stephen J.} and Aronson, {William J.} and Terris, {Martha K.} and Kane, {Christopher J.} and Christopher Amling and Cooperberg, {Matthew R.} and Vidal, {Adriana C.}",
year = "2015",
doi = "10.1111/bju.13182",
language = "English (US)",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy

T2 - Is adjuvant radiation warranted?

AU - Simon, Ross M.

AU - Howard, Lauren E.

AU - Freedland, Stephen J.

AU - Aronson, William J.

AU - Terris, Martha K.

AU - Kane, Christopher J.

AU - Amling, Christopher

AU - Cooperberg, Matthew R.

AU - Vidal, Adriana C.

PY - 2015

Y1 - 2015

N2 - Objectives: To determine if men with adverse pathology but undetectable ultrasensitive (

AB - Objectives: To determine if men with adverse pathology but undetectable ultrasensitive (

KW - Adjuvant radiotherapy

KW - Prostate

KW - Prostate-specific antigen

KW - Prostatic neoplasm

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=84932179230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932179230&partnerID=8YFLogxK

U2 - 10.1111/bju.13182

DO - 10.1111/bju.13182

M3 - Article

C2 - 26010251

AN - SCOPUS:84932179230

JO - BJU International

JF - BJU International

SN - 1464-4096

ER -